Unique ID issued by UMIN | UMIN000030591 |
---|---|
Receipt number | R000034935 |
Scientific Title | Safety evaluation of an excessive consumption of a food containing botanical extract - Placebo control double blind parallel group comparison clinical trial - |
Date of disclosure of the study information | 2018/01/05 |
Last modified on | 2018/05/08 14:51:40 |
Safety evaluation of an excessive consumption of a food containing botanical extract
- Placebo control double blind parallel group comparison clinical trial -
Safety evaluation of an excessive consumption of a food containing botanical extract
Safety evaluation of an excessive consumption of a food containing botanical extract
- Placebo control double blind parallel group comparison clinical trial -
Safety evaluation of an excessive consumption of a food containing botanical extract
Japan |
healthy subjects
Adult |
Others
NO
To evaluate the safety of excessive consumption of a food containing botanical extract for 4weeks
Safety
< Safety>
Side effect incidence, Adverse event incidence, clinical examination items, physiological examination items
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Study food
5 times of serving size per day for 4 weeks, safety evaluations are performed at 0, 2, 4 and 6 weeks
Control food
5 times of serving size per day for 4 weeks, safety evaluations are performed at 0, 2, 4 and 6 weeks
20 | years-old | <= |
65 | years-old | > |
Male and Female
1. Healthy males and females who equal to or more than 20 years and less than 65 years of age
2.Subjects who can visit the medical institution at the scheduled visit date
3. Subjects who are able to understand the study and willing to provide written informed consent
1. Subjects who systolic blood pressure is less than 90 mmHg
2. Subjects who equal to or more than 25kg/m of BMI
3. Subjects who given surgery, or taken medication due to serious illness within a month
4. Subject who present heart, liver, kidney disorders
5. Subjects who are taking drugs, foods for specified health use or functional foods which could affect this study
6. Subjects who Females in pregnancy, lactation and scheduled pregnancy period
7 Subjects who with heavy use of alcohol, and heavy smoking
8. Subject who have been felt ill by blood collection
9. Subjects who donated 200 ml or more of blood within a month prior to the study
10 Subjects who with irregular eating habits(Night shift worker)
11. Subjects who plan business trip or trip for 10 consecutive days or more
12. Subjects who have allergy related to the test foods
13. Subjects who have chronic diarrhea or chronic coprostasis
14.Subjects who already participating in other clinical trials, or planning to participate during this examination period
15. Subjects who can not agree with prliminary explanation
16. Subjects who are deemed to be unsuitable by the investigator
52
1st name | |
Middle name | |
Last name | Miura Hirona |
Higashi shinjuku Clinic
Hospital director
1-11-3, Okubo Shinjuku-ku, Tokyo
03-6233-8583
koike@meiseikai-cl.com
1st name | |
Middle name | |
Last name | Endoh Yoshiki |
New drug research center, Inc.
Clinical Research Dept.
452-1Toiso,Eniwa-shi,Hokkaido, Japan
0123-34-0412
y-endoh@ndrcenter.co.jp
Maruzen Pharmaceuticals Co., Ltd.
Maruzen Pharmaceuticals Co., Ltd.
Profit organization
NO
2018 | Year | 01 | Month | 05 | Day |
Unpublished
Completed
2017 | Year | 11 | Month | 29 | Day |
2018 | Year | 01 | Month | 09 | Day |
2017 | Year | 12 | Month | 27 | Day |
2018 | Year | 05 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034935